Beneficient's Q3 2026 results reflect a stabilizing business after leadership changes, evidenced by a 6.5% reduction in adjusted operating expenses and significant debt paydown while regaining NASDAQ compliance.

• Successfully closed first new GP primary commitment financing since June 2025, signaling renewed market interest.
• Achieved a 6.5% year-over-year decrease in adjusted operating expenses, and 18% year-to-date, excluding nonrecurring expenses.
• Generated approximately $50 million in gross proceeds through asset sales and equity redemptions, facilitating a $27.5 million debt reduction.
• Reinstated NASDAQ compliance after implementing extensive financial reviews and operational improvements.
• Resolved the GWG Holdings litigation, allowing a sharper focus on growth initiatives and enhancing shareholder value.